The role of ketamine in treatment-resistant depression: a systematic review Read More > September 12, 2014
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Read More > September 11, 2014
Blood d-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine Read More > September 5, 2014
Ketamine safety and tolerability in clinical trials for treatment-resistant depression Read More > September 2, 2014
Ketamine administration in depressive disorders: a systematic review and meta-analysis Read More > July 20, 2014
(R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function Read More > July 1, 2014
Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study Read More > July 1, 2014
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder Read More > June 11, 2014
